AIM ImmunoTech Inc. reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported revenue was USD 0.03 million compared to USD 0.023 million a year ago. Net loss was USD 4.85 million compared to USD 5.88 million a year ago. Basic loss per share from continuing operations was USD 0.1 compared to USD 0.12 a year ago.
For the six months, revenue was USD 0.064 million compared to USD 0.052 million a year ago. Net loss was USD 8.67 million compared to USD 9.46 million a year ago. Basic loss per share from continuing operations was USD 0.18 compared to USD 0.2 a year ago.